LDC completed the investment in Panthera Biopartners.

LDC, a mid-market private equity house, completed the investment in Panthera Biopartners, a UK-based site management organisation for commercial clinical trials. Financial terms were not disclosed. "Patient recruitment and dropout rates have historically been one of the biggest hurdles to efficient clinical trial processes and it’s this challenge that Panthera has proven it can solve. Stuart and his excellent team have built a trusted operation with well-established client relationships. We are looking forward to supporting them as they pursue their growth strategy," Grant Goodwin, LDC Investment Director.